Radiation oncology follow-up of prostate cancer survivors following completion of radiotherapy: a population-based study
Cerasuolo JO, Sussman J, Dayes IS, Sutradhar R, Zargoush M, Seow H. Curr Oncol. 2026; 33(1): 49.
Publications
Patterns and outcomes of completeness of revascularization in patients with diabetes and non-ST-segment-elevation myocardial infarction in Ontario, Canada
Godoy LC, Farkouh ME, Austin PC, Shah BR, Qiu F, Sud M, Nicolau JC, Razzouk L, Fremes SE, Lawler PR, Gaudino MFL, Ko DT. Circ Popul Health Outcomes. 2026; 19(2): e012310. Epub 2026 Jan 13.
Opioid dispensing prior to opioid toxicity hospitalizations and emergency department visits in Canada, 2018-2022
Hamzat B, Cheung G, Eurich DT, Kaboré JL, de Léséleuc L, Liu Z, McCormack D, Missaoui H, Randall JR, Shearer D, Stock D, Gomes T. PLoS One. 2026; 21(1): e0339643.
Timing of periprosthetic joint infections following primary and revision arthroplasty in Ontario: a population-based retrospective cohort study using administrative databases from 2003-2017
Kandel CE, Daneman N, Widdifield J, Jenkinson R, Hansen BE, McGeer AJ. J Arthroplasty. 2026; S0883-5403(26)00042-2. Epub 2026 Jan 10.
Effectiveness of an academic detailing service to support appropriate prescribing and care in patients with type 2 diabetes
Chu C, Ghahramani D, Rawn T, Burton V, Bevan L, Reidner B, Ivers N, Shuldiner J, Tadrous M. Fam Pract. 2026; 43(1):cmaf101.
Association of palliative care initiation with acute healthcare utilization among community-dwelling adults living with dementia
Quinn KL, Stukel TA, Pugliese M, Detsky AS, Heckman G, Omilabu MT, Stall NM, Vaz D, Webber C, Tanuseputro P, Isenberg S. J Am Geriatr Soc. 2026; Jan 9 [Epub ahead of print].
Real-world effectiveness and healthcare utilization of nivolumab for advanced head and neck cancer: a real-world population-based descriptive study
Dai WF, Nguyen L, Liu N, Chan KK. Oral Oncol. 2026; 173:107851. Epub 2026 Jan 8.
SARS-CoV-2 breakthrough infection among people with and without HIV in Ontario, Canada
Freitas C, Cooper CL, Kroch AE, Buchan SA, Moineddin R, Arbess G, Benoit AC, Chambers C, Habanyama M, Kendall CE, Kwong JC, Mbuagbaw L, McCullagh J, Moqueet N, Nambiar D, Tran V, Walmsley S, Burchell AN; CHESS Study Team; Langlois MA, Rueda S, Yeung A, Mah A, Lee S, Patrikar A, Taylor D. AIDS. 2026; 40(1): 119-122.
Validity of the leading causes of death classification for premature mortality in inflammatory bowel disease: a population-based comparison with ICD-10 coding in Ontario, Canada
Postill G, Kuenzig ME, Olivera PA, Itanyi IU, Harish V, Tang F, Buajitti E, Rosella LC, Benchimol EI. Clin Epidemiol. 2025; 17:1163-1175.
Impact of age and frailty on acute care use during immune checkpoint inhibitor treatment
Eng L, Faour E, Sutradhar R, Kaliwal Y, Niu Y, Liu N, Liu Y, Powis M, Liu G, Peppercorn JM, Krzyzanowska MK, Alibhai SMH. J Natl Cancer Inst. 2025; Dec 26 [Epub ahead of print].